Top

Journal of Neurology

Published in:

01-12-2012 | Letter to the Editors

Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies

Authors: Sanjeev Rajakulendran, Stuart Viegas, Jennifer Spillane, Robin S. Howard

Published in: Journal of Neurology | Issue 12/2012

Excerpt

Dear Sirs, …

Lindstrom JM, Einarson BL, Lennon VA, Seybold ME (1976) Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. J Exp Med 144(3):726–738PubMedCrossRef

Lavrnic D, Losen M, Vujic A, De Baets M, Hajdukovic LJ, Stojanovic V et al (2005) The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry 76(8):1099–1102PubMedCrossRef

Evoli A, Lindstrom J (2011) Myasthenia gravis with antibodies to MuSK: another step toward solving mystery? Neurology 77(20):1783–1784PubMedCrossRef

Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A (2003) Clinical aspects of MuSK antibody positive seronegative MG. Neurology 60(12):1978–1980PubMedCrossRef

Diaz-Manera J, Rojas-Garcia R, Gallardo E, Juarez C, Martinez-Domeno A, Martinez-Ramirez S et al (2007) Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan’s syndrome. Nat Clin Pract Neurol 3(7):405–410PubMedCrossRef

Kostera-Pruszczyk A, Kwiecinski H (2009) Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy. J Neurol 256(10):1780–1781PubMedCrossRef

Saulat B, Maertens P, Hamilton WJ, Bassam BA (2007) Anti-musk antibody after thymectomy in a previously seropositive myasthenic child. Neurology 69(8):803–804PubMedCrossRef

Sanders DB, Juel VC (2008) MuSK-antibody positive myasthenia gravis: questions from the clinic. J Neuroimmunol 15(201–202):85–89CrossRef

O’Riordan JI, Miller DH, Mottershead JP, Pattison C, Hirsch NP, Howard RS (1998) Thymectomy: its role in the management of myasthenia gravis. Eur J Neurol 5(2):203–209PubMedCrossRef

10.

Hatanaka Y, Hemmi S, Morgan MB, Scheufele ML, Claussen GC, Wolfe GI et al (2005) Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG. Neurology 65(9):1508–1509PubMedCrossRef

11.

Pasnoor M, Wolfe GI, Nations S, Trivedi J, Barohn RJ, Herbelin L et al (2010) Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience. Muscle Nerve 41(3):370–374PubMedCrossRef

12.

Bhibhatbhan A, Kline G, Vincent A, Toth C (2007) Anti-MuSK myasthenia gravis presenting with Epstein–Barr virus-associated mononucleosis and immune-mediated diabetes mellitus. Muscle Nerve 36(2):264–266PubMedCrossRef

13.

Savino W, Berrih S (1984) Thymic extracellular matrix in myasthenia gravis. Lancet 2(8393):45–46PubMedCrossRef

14.

Berrih S, Morel E, Gaud C, Raimond F, Le Brigand H, Bach JF (1984) Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis. Neurology 34(1):66–71PubMedCrossRef

15.

Leite MI, Strobel P, Jones M, Micklem K, Moritz R, Gold R et al (2005) Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol 57(3):444–448PubMedCrossRef

16.

Gerli R, Paganelli R, Cossarizza A, Muscat C, Piccolo G, Barbieri D et al (1999) Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol 103(5 Pt 1):865–872PubMedCrossRef

Title: Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies
Authors: Sanjeev Rajakulendran
Stuart Viegas
Jennifer Spillane
Robin S. Howard
Publication date: 01-12-2012
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 12/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-012-6661-9

At a glance: The STEP trials

Springer Medicine

Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2012

Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value

Fronto-striatal dysfunction in type 3 familial cortical myoclonic tremor epilepsy occurring during aging

Neurological symptoms in individuals with fibrodysplasia ossificans progressiva

Alterations in functional connectivity of the amygdala in unilateral mesial temporal lobe epilepsy

Vitamin D levels in Hispanics with multiple sclerosis

Sleep, behavioral rhythms, and neurological disease